CpG island hypermethylation in progression of esophageal and gastric cancer

Fumiaki Sato, Stephen J. Meltzer

Research output: Contribution to journalReview articlepeer-review


The upper gastrointestinal (GI) cancers have various carcinogenic pathways and precursor lesions, such as dysplasia for esophageal squamous cell carcinoma, Barrett esophagus for esophageal adenocarcinoma, and intestinal metaplasia for the intestinal-type of gastric cancer. Recently, many epigenetic events in carcinogenic pathways have been revealed, along with genomic and genetic alterations. This information has provided deeper insight into an understanding of the mechanisms of upper GI carcinogenesis. Moreover, detection methods of aberrant methylation have been applied to clinical fields to stratify high-risk groups, detect early cancer, and to predict clinical outcomes. In this review, a variety of information is summarized regarding gene hypermethylation in esophageal and gastric cancer.

Original languageEnglish (US)
Pages (from-to)483-493
Number of pages11
Issue number3
StatePublished - Feb 1 2006
Externally publishedYes


  • CIMP
  • Carcinogenesis
  • Early detection
  • Esophageal cancer
  • Gastric cancer
  • H. Pylori
  • Hypermethylation
  • Microsatellite instability

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'CpG island hypermethylation in progression of esophageal and gastric cancer'. Together they form a unique fingerprint.

Cite this